CT0591CP
/ The First Affiliated Hospital of Soochow University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 12, 2023
This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: The First Affiliated Hospital of Soochow University | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Multiple Myeloma • Oncology
August 04, 2022
This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Soochow University
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 2
Of
2
Go to page
1